These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 29320969)

  • 1. Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.
    Hachim MY; Hachim IY; Dai M; Ali S; Lebrun JJ
    Tumour Biol; 2018 Jan; 40(1):1010428317748254. PubMed ID: 29320969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ1 neutralization displays therapeutic efficacy through both an immunomodulatory and a non-immune tumor-intrinsic mechanism.
    Canè S; Van Snick J; Uyttenhove C; Pilotte L; Van den Eynde BJ
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33637600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of differences in expression pattern of three isoforms of the transforming growth factor beta in patients with lumbosacral stenosis.
    Sobański D; Bogdał P; Staszkiewicz R; Sobańska M; Filipowicz M; Czepko RA; Strojny D; Grabarek BO
    Cell Cycle; 2024 Mar; 23(5):555-572. PubMed ID: 38695374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical Redox Imaging Is Responsive to TGFβ Receptor Signalling in Triple-Negative Breast Cancer Cells.
    Xu HN; Jacob A; Li LZ
    Adv Exp Med Biol; 2022; 1395():269-274. PubMed ID: 36527648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbation of the transforming growth factor β system in Turner syndrome.
    Zhou J; Arepalli S; Cheng CM; Bakalov VK; Bondy CA
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):720-4. PubMed ID: 23073581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of cancer.
    Gupta A; Budhu S; Fitzgerald K; Giese R; Michel AO; Holland A; Campesato LF; van Snick J; Uyttenhove C; Ritter G; Wolchok JD; Merghoub T
    Commun Biol; 2021 Nov; 4(1):1296. PubMed ID: 34789823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding requirements for latent transforming growth factor Beta2 activation.
    Sachan N; Phoon CKL; Bu L; Zilberberg L; Ahamed J; Rifkin DB
    Matrix Biol Plus; 2024 Jun; 22():100149. PubMed ID: 38831847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in Expression of Inflammation-Related Signaling Molecules with Profibrotic and Antifibrotic Effects in Cutaneous and Oral Mucosa Scars.
    Bucur M; Dinca O; Vladan C; Popp C; Nichita L; Cioplea M; Stînga P; Mustatea P; Zurac S; Ionescu E
    J Immunol Res; 2018; 2018():5196023. PubMed ID: 30622976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced S-nitrosylation of TGFβ1 elevates its binding affinity towards the receptor and promotes fibrogenic signaling in the breast.
    Letson J; Furuta S
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the Chemical Space of Transforming Growth Factor-β (TGFβ) Receptor Type II Degraders with 3,4-Disubstituted Indole Derivatives.
    Längle D; Wojtowicz-Piotrowski S; Priegann T; Keller N; Wesseler F; Reckzeh ES; Steffens K; Grathwol C; Lemke J; Flasshoff M; Näther C; Jonson AC; Link A; Koch O; Di Guglielmo GM; Schade D
    ACS Pharmacol Transl Sci; 2024 Apr; 7(4):1069-1085. PubMed ID: 38633593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoglin (CD105) and SMAD4 regulate spheroid formation and the suppression of the invasive ability of human pancreatic cancer cells.
    Kokaji E; Shimomura A; Minamisaka T; Nakajima T; Miwa S; Hatta H; Nishida T; Kiya C; Imura J
    Int J Oncol; 2018 Mar; 52(3):892-900. PubMed ID: 29393426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.
    Vitiello GAF; Guembarovski RL; Hirata BKB; Amarante MK; de Oliveira CEC; de Oliveira KB; Cebinelli GCM; Guembarovski AL; Campos CZ; Watanabe MAE
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):645-655. PubMed ID: 29362917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer.
    Tang YA; Chen YF; Bao Y; Mahara S; Yatim SMJM; Oguz G; Lee PL; Feng M; Cai Y; Tan EY; Fong SS; Yang ZH; Lan P; Wu XJ; Yu Q
    Proc Natl Acad Sci U S A; 2018 Jun; 115(26):E5990-E5999. PubMed ID: 29891662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin hormone exerts anti-tumorigenic effects in HER-2 overexpressing breast cancer cells through regulation of stemness.
    Hachim IY; López-Ozuna VM; Hachim MY; Lebrun JJ; Ali S
    Stem Cell Res; 2019 Oct; 40():101538. PubMed ID: 31450192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant Expression of Prolactin Receptor and TGFβ Receptors in Breast Cancer: Association with Less Aggressive Phenotype and Favorable Patient Outcome.
    Hachim IY; López-Ozuna VM; Hachim MY; Lebrun JJ; Ali S
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin modulates TNBC aggressive phenotype limiting tumorigenesis.
    López-Ozuna VM; Hachim IY; Hachim MY; Lebrun JJ; Ali S
    Endocr Relat Cancer; 2019 Mar; 26(3):321-337. PubMed ID: 30640712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenoestrogen and Its Interaction with Human Genes and Cellular Proteins: An In-Silico Study.
    Warrier AV; Vg M; R L N; Krishnan N; Kumari P; Ittycheria SS; Srinivas P
    Asian Pac J Cancer Prev; 2024 Jun; 25(6):2077-2087. PubMed ID: 38918670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vitamin D supplementation on inflammatory markers and total antioxidant capacity in breast cancer women using a machine learning technique.
    Tahmasebi M; Veissi M; Hosseini SA; Jamshidnezhad A
    Explor Target Antitumor Ther; 2023; 4(5):1059-1070. PubMed ID: 38023986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology-based strategy for predicting therapy targets of Ecliptae Herba on breast cancer.
    Li H; Shi W; Shen T; Hui S; Hou M; Wei Z; Qin S; Bai Z; Cao J
    Medicine (Baltimore); 2023 Oct; 102(41):e35384. PubMed ID: 37832105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remarkable sex-specific differences at single-cell resolution in neonatal hyperoxic lung injury.
    Cantu A; Gutierrez MC; Dong X; Leek C; Sajti E; Lingappan K
    Am J Physiol Lung Cell Mol Physiol; 2023 Jan; 324(1):L5-L31. PubMed ID: 36283964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.